Acella Pharmaceuticals recalls 100-count NP Thyroid 15 tablets (15 mg) due to subpotent levothyroxine content. FDA analysis shows these products contain less active ingredient than labeled, potentially causing inadequate thyroid hormone levels.
“Acella NP Thyroid 15 Tablets Recall: Subpotent Levothyroxine Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36769-acella-np-thyroid-15-tablets-recall-subpotent-levothyroxine-risk. Based on FDA recall #D-0035-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0035-2021%22&limit=1).
The FDA announced on September 17, 2020, that Acella Pharmaceuticals voluntarily recalled NP Thyroid 15 tablets due to subpotent drug risks. The agency found the levothyroxine content was less than labeled claims.
FDA analysis found the products to be less than the labeled claim for the levothyroxine (T4) portion of the product. The recall is classified as Class I.
Context
GovInfoNow's records show Acella Pharmaceuticals has had seven other recalls since May 22, 2020. Recent brand recalls include a lead and lithium contamination risk in Naproxen Suspension on April 20, 2026, and failed dissolution testing in Doxycycline Tablets on September 29, 2025. Other recent recalls of similar products include Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), Accord Healthcare Levothyroxine Tablets Recall (August 6, 2026), and Macleods Levothyroxine Tablets Recall (February 26, 2026).
How to tell if you have this one
Check for 100-count NP Thyroid 15 tablets (15 mg) with NDC 42192-327-01, manufactured in Alpharetta, GA, lot M327E19-1, expiring 10/2020. The product is prescription-only.
Brand
Acella
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
The recall record indicates the product may not provide enough thyroid hormone, so it's not recommended for use as intended without consulting a healthcare provider.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0035-2021 (September 17, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0035-2021 to see it in context.
Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.